Member LoginMember Login - User registration - Setup as front page - Add to favorites - Sitemap Complex stories of migration are among the finalists for the Women's Prize for Fiction !

Complex stories of migration are among the finalists for the Women's Prize for Fiction

Time:2024-05-21 16:40:39 source:Culture Current news portal

LONDON (AP) — Two novels that tell complex and surprising stories of migration are among six finalists for the 2024 Women’s Prize for Fiction.

U.S.-French writer Aube Rey Lescure’s debut novel “River East, River West” depicts west to east immigration through the story of Americans in China, while British author Isabella Hammad’s “Enter Ghost” charts a Shakespearean actress’s complicated return to her Palestinian homeland.

The shortlist announced Wednesday for the 30,000 pound ($37,000) award includes two Irish writers: Claire Kilroy, for her story of motherhood, “Soldier, Sailor,” and Anne Enright for multigenerational saga “The Wren, The Wren.”

Australia’s Kate Grenville, a previous Women’s Prize winner, makes the list with her eighth novel, historical adventure “Restless Dolly Maunder.” U.S. writer V. V. Ganeshananthan is nominated for her second novel, “Brotherless Night,” set during Sri Lanka’s civil war.

Related information
  • Election 2024: Biden and Trump bypassed the Commission on Presidential Debates
  • China's Hubei launches first freight train via China
  • Xi Presents Order to Promote Military Officers to Rank of General
  • U.S. doubles down on vaccination efforts as Delta variant drives COVID
  • Shooting injures 2 at Missouri high school graduation ceremony
  • Tokyo 2020 Paralympic Games open
  • Xiplomacy: China
  • Heavy rains kill 253 in S. Africa
Recommended content
  • Inquiry slams UK authorities for failures that killed thousands in infected blood scandal
  • 2023 Edition of 'Xi Jinping on the Belt and Road Initiative' Published
  • Midsummer Day celebrated in Bucharest, Romania
  • (W.E. Talk) Can China and the U.S. Escape the Thucydides Trap?
  • Pope trip to Luxembourg, Belgium confirmed for September, 2 weeks after challenging Asia visit
  • WHO endorses China's Sinopharm COVID